Literature DB >> 9223496

Both T and B cells shed infectious mouse mammary tumor virus.

J L Dzuris1, T V Golovkina, S R Ross.   

Abstract

Mouse mammary tumor virus (MMTV) infected both B and T tissue culture cells and primary B and T cells in vivo after milk-borne transmission of the virus. The infected tissue culture cells processed viral proteins, and both these and primary B and T cells shed virus when cultured in vitro. Moreover, the infected B and T tissue culture cells transmitted virus to uninfected mammary gland cells in vitro. The level of infection of these different cell types in vivo was dependent on the strain of mouse, with C3H/HeN mice showing greater B-cell infection and BALB/c mice greater T-cell infection after nursing on MMTV-infected C3H/HeN mothers. Although their B cells were less infected, BALB/c mice developed tumors more rapidly than C3H/HeN mice. These results indicate that both infected T and B cells are potential carriers of MMTV in vivo.

Entities:  

Mesh:

Year:  1997        PMID: 9223496      PMCID: PMC191862     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

Review 1.  Superantigens: bacterial and viral proteins that manipulate the immune system.

Authors:  M T Scherer; L Ignatowicz; G M Winslow; J W Kappler; P Marrack
Journal:  Annu Rev Cell Biol       Date:  1993

2.  Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.

Authors:  G Schochetman; L O Arthur; C W Long; R J Massey
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

3.  Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range.

Authors:  T V Golovkina; A B Jaffe; S R Ross
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection.

Authors:  T V Golovkina; J P Dudley; A B Jaffe; S R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

Review 5.  Superantigens of mouse mammary tumor virus.

Authors:  H Acha-Orbea; H R MacDonald
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

6.  Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses.

Authors:  T V Golovkina; I Piazzon; I Nepomnaschy; V Buggiano; M de Olano Vela; S R Ross
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

8.  Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function.

Authors:  W Held; G A Waanders; H Acha-Orbea; H R MacDonald
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

9.  Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model.

Authors:  O Karapetian; A N Shakhov; J P Kraehenbuhl; H Acha-Orbea
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells.

Authors:  T V Golovkina; A Chervonsky; J A Prescott; C A Janeway; S R Ross
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  21 in total

1.  A murine retrovirus co-Opts YB-1, a translational regulator and stress granule-associated protein, to facilitate virus assembly.

Authors:  Darrin V Bann; Andrea R Beyer; Leslie J Parent
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

2.  A novel mechanism of resistance to mouse mammary tumor virus infection.

Authors:  T V Golovkina
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Interleukin-4 up-regulates mouse mammary tumor virus expression yet is not required for in vivo virus spread.

Authors:  J Czarneski; J Meyers; T Peng; V Abraham; R Mick; S R Ross
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor.

Authors:  Spyridon Stavrou; Wenming Zhao; Kristin Blouch; Susan R Ross
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

5.  Jaagsiekte retrovirus is widely distributed both in T and B lymphocytes and in mononuclear phagocytes of sheep with naturally and experimentally acquired pulmonary adenomatosis.

Authors:  M J Holland; M Palmarini; M Garcia-Goti; L Gonzalez; I McKendrick; M de las Heras; J M Sharp
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus promoter.

Authors:  K Aurrekoetxea-Hernández; E Buetti
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Passive immunization with neutralizing antibodies interrupts the mouse mammary tumor virus life cycle.

Authors:  M Mpandi; L A Otten; C Lavanchy; H Acha-Orbea; D Finke
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Mammary gland expression of mouse mammary tumor virus is regulated by a novel element in the long terminal repeat.

Authors:  W Qin; T V Golovkina; T Peng; I Nepomnaschy; V Buggiano; I Piazzon; S R Ross
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 9.  Mouse mammary tumor virus and the immune system.

Authors:  Jennifer Czarneski; John C Rassa; Susan R Ross
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  A novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice.

Authors:  Chioma M Okeoma; Ming Shen; Susan R Ross
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.